New

Adequan I.M. for Horses, 50ml Injection (100mg/ml) - Multi-Dose Vial

NV95901

View related products

The only FDA-approved equine PSGAG (polysulfated glycosaminoglycan) recommended for the intramuscular treatment for non-infectious degenerative joint disease (DJD) of the carpal and hock joints.

Proven to:

  • Reduce inflammation
  • Restore synovial joint lubrication
  • Repair joint cartilage
  • Reverse the disease process

Related Documents

Log-in to purchase
Complementary Content
${loading}